Skip to main content
. 2021 Mar 22;21:100. doi: 10.1186/s12906-021-03270-w

Table 2.

Antibodies used in the study

Antibodies Manufacturer Catalogue No. Observed MW Dilution
Anti-PI3K Proteintech 67,071–1-1 g 110 KDa 1:10,000
Anti-p-Akt Proteintech 66,444–1-1 g 62 KDa 1:10,000
Anti-Akt Proteintech 10,176–2-AP 56 KDa 1:5000
Anti-p-Bad Cell Signaling Technology 5284S 23 KDa 1:1000
Anti-Bad Proteintech 10,435–1-AP 18 KDa 1:2500
Anti-Bcl-2 Proteintech 26,593–1-AP 26 KDa 1:2500
Anti-Bax Proteintech 50,599–2-1 g 26 KDa 1:10,000
Anti-Caspase-3 Proteintech 19,677–1-AP 32 KDa 1:2000
Anti-cleaved-Caspase-3 Abcam ab49822 17 KDa 1:500
Anti-Caspase-9 Proteintech 10,380–1-AP 47 KDa 1: 1000
Anti-cleaved-Caspase-9 Affinity Biosciences AF5240 10 KDa 1: 1000
Anti-PARP1 Proteintech 13,371–1-AP 89 KDa 1:2000
Anti-Cyt-c Proteintech 12,245–1-AP 13 KDa 1:2000
Anti-Mfn1 Proteintech 13,798–1-AP 86 KDa 1:1000
Anti-Mfn2 Proteintech 12,186–1-AP 86 KDa 1:5000
Anti-Drp1 Proteintech 10,656–1-AP 27 KDa 1:4000
Anti-PGC1a Proteintech 66,369–1-1 g 100 KDa 1:5000
Anti-Nrf1 Proteintech 12,482–1-AP 67 KDa 1:2500
Anti-Tfam Proteintech 22,586–1-AP 25 KDa 1:5000
Anti-GAPDH Proteintech 60,004–1-1 g 36 KDa 1:10,000